In The News

16 October 2025
AI unlocks the hidden grammar of gene regulation
From ASBMB, the Zeitlinger Lab studies how protein transcription factors, or TFs, bind to DNA to regulate gene expression, using fruit flies as her model.
Read Article
By Jessica Johns Pool
During his graduate training, Camahort had an inkling a professorship was not in his future and he started to explore possible careers outside of academia. While enrolled in the doctoral program at the University of Kansas and completing degree requirements in the lab of Jennifer Gerton, PhD, he interned at the Kansas City Police Department Crime Lab. As he recalls, DNA testing was not nearly as thrilling as portrayed on the television show CSI: Crime Scene Investigation.
After completing the PhD program, Camahort moved to Harvard University to pursue postdoctoral training. During this time, he was a teaching fellow for a couple of semesters, and although he enjoyed teaching, Camahort felt he still hadn’t found his niche.
While completing a National Institutes of Health postdoctoral fellowship in medicine at Harvard, Camahort did an internship in embryology at the Fertility Center of New England, and an internship in business development at Partners HealthCare Research Ventures and Licensing, which commercializes inventions and treatments developed in labs at Brigham and Women’s Hospital and Massachusetts General Hospital. The business development internship gave Camahort a window into the commercial side of science and it intrigued him.
“Moving out of academia and into the commercial side of science isn’t unusual in the Boston area,” says Camahort. “At the Stowers Institute, I was frequently thinking outside the academic box. All of those internships helped me hone what I really liked about a career in science.”
Camahort joined Novo Ventures (US) Inc., a life sciences venture capital firm in Cambridge, Massachusetts, in 2015. Now, he uses his ten-plus years of combined research and business development experience to assess the potential of companies bringing new drugs or medical devices to the market.
“I perform diligence for new investments for companies trying to raise money for clinical trials or to launch a new treatment,” says Camahort. “I read more papers now than I ever did as a predoc or postdoc. In a nutshell, when you’re in a lab, you are digging deeply into one topic. Now it’s much more broad. I dig into many things.”
Camahort stays in touch with his former colleagues at the Institute including his mentor, Investigator Jennifer Gerton, PhD, and Stowers alumni who pass through Boston. In fact, he recently helped a former Stowers colleague move into a new Boston-area home.
Camahort credits the Institute with deepening his love of science and his desire to stay in the field, even if he didn’t remain in basic science research.
“The Stowers Institute doesn’t put any limits on your creativity or your scientific pursuit,” recalls Camahort. “They have the resources to allow you to do what it takes for top-notch work. That kind of freedom and the collaborative environment is unique.”
For young scientists just beginning their career journey, Camahort recommends they consider career options outside the research lab. “Every day I use what I learned in the lab. The scientific context of my work now is translational and commercial, rather than basic discovery, but it’s just as interesting.”
In The News
16 October 2025
From ASBMB, the Zeitlinger Lab studies how protein transcription factors, or TFs, bind to DNA to regulate gene expression, using fruit flies as her model.
Read Article
In The News
16 October 2025
From The Scientist, research from the Sánchez Alvarado Lab shows stem cells in regenerating planarians don’t need their closest neighbors, overturning researchers’ understanding of the worms’ regenerative superpowers.
Read Article
Press Release
15 October 2025
Stowers scientists discover new rules about how flatworm stem cells regrow body parts, offering insights into potential tissue repair and regenerative medicine in humans.
Read Article
In The News
10 October 2025
From NPR's All Things Considered, in the human body, cells are constantly making life-or-death decisions. If they make the wrong choice, the result can be cancer, infection or even Alzheimer's.
Read Article